1.7606
                                            Schlusskurs vom Vortag:
              $1.50
            Offen:
              $1.65
            24-Stunden-Volumen:
                1.35M
            Relative Volume:
              1.08
            Marktkapitalisierung:
                $289.13M
            Einnahmen:
              $400.57M
            Nettoeinkommen (Verlust:
              $9.21M
            KGV:
              44.02
            EPS:
                0.04
            Netto-Cashflow:
                $146.36M
            1W Leistung:
              +9.08%
            1M Leistung:
              +38.22%
            6M Leistung:
                +94.22%
            1J Leistung:
              -54.16%
            Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Firmenname
                  
                      Ironwood Pharmaceuticals Inc
                    
                Sektor
                  Telefon
                  
                      617-621-7722
                    
                Adresse
                  
                      100 SUMMER STREET, SUITE 2300, BOSTON, MA
                    
                Vergleichen Sie IRWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                IRWD
                            
                             Ironwood Pharmaceuticals Inc | 1.78 | 243.65M | 400.57M | 9.21M | 146.36M | 0.04 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 143.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.45 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.2397 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.11 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 448.27 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-04-15 | Herabstufung | Jefferies | Buy → Hold | 
| 2025-04-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight | 
| 2025-04-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform | 
| 2024-09-09 | Eingeleitet | Leerink Partners | Market Perform | 
| 2024-08-08 | Herabstufung | CapitalOne | Overweight → Equal Weight | 
| 2024-01-17 | Eingeleitet | Craig Hallum | Buy | 
| 2023-12-14 | Eingeleitet | Wells Fargo | Overweight | 
| 2023-11-09 | Eingeleitet | Jefferies | Buy | 
| 2023-09-28 | Eingeleitet | JMP Securities | Mkt Outperform | 
| 2022-09-02 | Eingeleitet | CapitalOne | Overweight | 
| 2022-04-22 | Eingeleitet | Piper Sandler | Overweight | 
| 2020-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight | 
| 2020-06-17 | Eingeleitet | Northland Capital | Outperform | 
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral | 
| 2019-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight | 
| 2019-02-25 | Hochstufung | H.C. Wainwright | Sell → Neutral | 
| 2019-01-24 | Hochstufung | JP Morgan | Underweight → Neutral | 
| 2018-11-07 | Herabstufung | Credit Suisse | Outperform → Neutral | 
| 2018-11-07 | Herabstufung | JP Morgan | Neutral → Underweight | 
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Sell | 
| 2018-05-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight | 
| 2018-01-05 | Herabstufung | BofA/Merrill | Buy → Underperform | 
| 2017-12-06 | Herabstufung | Mizuho | Buy → Neutral | 
| 2017-07-21 | Herabstufung | JP Morgan | Overweight → Neutral | 
| 2017-05-03 | Eingeleitet | Wells Fargo | Outperform | 
| 2017-04-07 | Bestätigt | Mizuho | Buy | 
| 2017-02-22 | Bestätigt | Barclays | Equal Weight | 
| 2016-11-04 | Bestätigt | Mizuho | Buy | 
| 2016-10-24 | Bestätigt | Wedbush | Neutral | 
| 2016-10-10 | Bestätigt | Mizuho | Buy | 
| 2016-09-27 | Bestätigt | WallachBeth | Hold | 
                    Alle ansehen
                     
                  
                Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Ironwood Pharmaceuticals (IRWD) Expected to Announce Earnings on Thursday - MarketBeat
Live market analysis of Ironwood Pharmaceuticals Inc.July 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Will Ironwood Pharmaceuticals Inc. bounce back from current supportJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.July 2025 Action & Weekly Top Stock Performers List - newser.com
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidityWeekly Risk Report & Stock Market Timing Techniques - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
Pattern recognition hints at Ironwood Pharmaceuticals Inc. upside2025 Stock Rankings & Scalable Portfolio Growth Ideas - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 2025Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveAnalyst Downgrade & Verified Momentum Stock Ideas - newser.com
Why Ironwood Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock now2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Ironwood Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Will Ironwood Pharmaceuticals Inc. outperform the market2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Published on: 2025-10-28 05:42:32 - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Hold" by Analysts - MarketBeat
How to use a screener to detect Ironwood Pharmaceuticals Inc. breakoutsGap Down & Free Long-Term Investment Growth Plans - newser.com
Will Ironwood Pharmaceuticals Inc. stock reach all time highs in 2025Earnings Trend Report & Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Real time breakdown of Ironwood Pharmaceuticals Inc. stock performance2025 Sector Review & Proven Capital Preservation Methods - newser.com
Aug Macro: Will Ironwood Pharmaceuticals Inc. stock recover faster than market2025 Bull vs Bear & Low Risk High Reward Trade Ideas - Fundação Cultural do Pará
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ironwood Pharmaceuticals Inc-Aktie (IRWD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt | 
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer | Aug 11 '25 | Sale | 0.84 | 7,754 | 6,513 | 400,378 | 
| Martini Gregory S. | Chief Financial Officer | Aug 11 '25 | Sale | 0.84 | 1,265 | 1,063 | 182,545 | 
| Silver Ronald | Principal Accounting Officer | Aug 11 '25 | Sale | 0.84 | 2,846 | 2,391 | 276,809 | 
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App